AtonRa Partners - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
AtonRa Partners ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$863,000
-38.5%
13,505
+3.0%
0.47%
-3.9%
Q4 2021$1,404,000
+11.6%
13,111
+7.1%
0.49%
+16.2%
Q3 2021$1,258,000
+25.5%
12,238
+7.4%
0.42%
+14.4%
Q2 2021$1,002,000
+18.2%
11,397
+30.7%
0.37%
-2.9%
Q1 2021$848,000
+12.3%
8,723
+29.6%
0.38%
+2.2%
Q4 2020$755,0006,7320.37%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders